The CEACAM1 expression is decreased in the liver of severely obese patients with or without diabetes.
about
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysisCeacam1 deletion causes vascular alterations in large vesselsHigh-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion.Comparison of TCDD-elicited genome-wide hepatic gene expression in Sprague-Dawley rats and C57BL/6 mice.Influences of gestational obesity on associations between genotypes and gene expression levels in offspring following maternal gastrointestinal bypass surgery for obesity.Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin ResistanceCEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).Adenovirus36 infection expresses cellular APMI and Visfatin genes in overweight Uygur individuals.Reduced Hepatic Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Level in Obesity.Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis.Loss of Hepatic CEACAM1: A Unifying Mechanism Linking Insulin Resistance to Obesity and Non-Alcoholic Fatty Liver DiseasePrehepatic secretion and disposal of insulin in obese adolescents as estimated by three-hour, eight-sample oral glucose tolerance tests.Hepatic CEACAM1 Over-Expression Protects Against Diet-Induced Fibrosis and Inflammation in White Adipose Tissue.CEACAM1 as a multi-purpose target for cancer immunotherapy.High blood glucose levels are associated with higher risk of colon cancer in men: a cohort study.Liver-specific reconstitution of CEACAM1 reverses the metabolic abnormalities caused by its global deletion in male mice.Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis.The cell biology of systemic insulin function.Exenatide induces carcinoembryonic antigen-related cell adhesion molecule 1 expression to prevent hepatic steatosis.
P2860
Q27008886-B471344D-6D18-4A93-BE42-55250642A4BBQ28505518-E14564BF-66F6-4963-A3D4-AD3A5952B7FEQ30278680-4B794C77-2C5C-4F1A-B927-CFB75C88AADAQ33923892-CC201EC5-579E-4E02-ADFE-A031C93D112FQ34988941-AE1B319B-0B01-44F9-B706-014E182CF19AQ35881723-35A7CF7D-3E7C-4CC5-840E-AEB95C10C6DFQ37624585-7D0028B1-6F2B-444F-BFBE-D484EB4171A4Q37718156-ECE2FFEE-62D6-4560-8A84-F2FE23D6E7AEQ37721741-6716650B-580D-46E7-BC88-A855E1A05D06Q38125604-12064D02-4224-42E6-AF5D-0913FB2E364EQ39128964-ED99DB22-07F0-4BD0-BA77-9BB8BA32E1D8Q39796669-47B910C4-F741-41BB-837B-EED6B41EE9BBQ40631328-0B0E669A-794F-4869-9FC1-3F3F4C00987BQ41251368-4A317E5B-EC9D-4347-9C50-A92D42FA7643Q48131625-618153FE-C78D-42AC-B032-FCBF9BB6B215Q50075578-1B264F9F-B94B-4042-AB3D-1790F2B676DFQ51365355-125AA8DD-5D29-408C-B033-DAB3051E6AD8Q52603907-6559048F-758F-4707-ABA0-E0F9D4A1F733Q54941250-B5E630D7-3897-4ADC-95DF-C5976BA984D1
P2860
The CEACAM1 expression is decreased in the liver of severely obese patients with or without diabetes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The CEACAM1 expression is decr ...... ents with or without diabetes.
@en
The CEACAM1 expression is decr ...... ents with or without diabetes.
@nl
type
label
The CEACAM1 expression is decr ...... ents with or without diabetes.
@en
The CEACAM1 expression is decr ...... ents with or without diabetes.
@nl
prefLabel
The CEACAM1 expression is decr ...... ents with or without diabetes.
@en
The CEACAM1 expression is decr ...... ents with or without diabetes.
@nl
P2860
P356
P1433
P1476
The CEACAM1 expression is decr ...... ents with or without diabetes.
@en
P2093
P2860
P2888
P356
10.1186/1746-1596-6-40
P577
2011-05-11T00:00:00Z
P5875
P6179
1009991448